Aytu Historical Financial Ratios

AYTU Stock

USD 1.62 0.02 1.25%

Aytu BioScience is presently reporting on over 103 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 3.34 or Days Sales Outstanding of 106 will help investors to properly organize and evaluate Aytu BioScience financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aytu BioScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.

About Aytu Financial Ratios Analysis

Aytu BioScienceFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Aytu BioScience investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Aytu financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Aytu BioScience history.

Aytu BioScience Financial Ratios Chart

At this time, Aytu BioScience's Research And Ddevelopement To Revenue is comparatively stable compared to the past year. Cash Per Share is likely to gain to about 293.3 K in 2024, whereas Operating Cash Flow Per Share is likely to drop (611.3 K) in 2024.

Price To Sales Ratio Days Sales Outstanding Book Value Per Share Ev To Free Cash Flow Return On Capital Employed Free Cash Flow Operating Cash Flow Ratio

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Aytu BioScience stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Aytu BioScience sales, a figure that is much harder to manipulate than other Aytu BioScience multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Most ratios from Aytu BioScience's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Aytu BioScience current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aytu BioScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.At this time, Aytu BioScience's Research And Ddevelopement To Revenue is comparatively stable compared to the past year. Cash Per Share is likely to gain to about 293.3 K in 2024, whereas Operating Cash Flow Per Share is likely to drop (611.3 K) in 2024.

	2021	2022	2023	2024 (projected)
Days Sales Outstanding	81.98	98.34	106.42	106.07
PTB Ratio	0.44	0.14	0.57	3.34

Days Sales Outstanding Ptb Ratio

Aytu BioScience fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.78	0.01	0.19	0.26	-0.5	-0.17	-0.12	0.78	0.99	-0.47	0.05	-0.14	-0.27	0.07	-0.9	-0.25	-0.06	0.18	-0.1	-0.77	0.17	-0.1	-0.12	0.14	0.11
Ptb Ratio	0.78		-0.33	-0.17	0.25	-0.17	-0.24	-0.39	1.0	0.82	-0.16	-0.46	-0.39	-0.09	0.32	-0.72	0.18	-0.37	-0.16	-0.11	-0.36	0.42	-0.11	-0.41	0.01	-0.48
Days Sales Outstanding	0.01	-0.33		0.83	0.24	-0.54	0.46	0.68	-0.33	-0.14	-0.48	0.44	0.22	-0.21	-0.4	-0.14	-0.44	0.67	0.72	0.1	-0.56	-0.68	0.1	0.88	0.03	0.48
Book Value Per Share	0.19	-0.17	0.83		0.06	-0.89	0.72	0.91	-0.17	0.03	-0.86	0.23	0.06	-0.68	-0.3	-0.41	-0.61	0.92	0.98	0.29	-0.74	-0.85	0.29	0.94	0.12	0.37
Free Cash Flow Yield	0.26	0.25	0.24	0.06		-0.09	-0.21	0.01	0.25	0.25	-0.08	0.31	0.14	-0.01	-0.05	-0.12	-0.31	0.04	0.05	-0.5	-0.07	-0.07	-0.5	-0.02	-0.29	0.17
Operating Cash Flow Per Share	-0.5	-0.17	-0.54	-0.89	-0.09		-0.66	-0.79	-0.17	-0.37	1.0	-0.05	0.06	0.87	0.19	0.68	0.62	-0.82	-0.93	-0.26	0.83	0.72	-0.25	-0.69	-0.08	-0.24
Average Payables	-0.17	-0.24	0.46	0.72	-0.21	-0.66		0.79	-0.24	-0.28	-0.67	-0.3	-0.14	-0.67	-0.07	-0.14	-0.3	0.77	0.74	0.41	-0.31	-0.74	0.4	0.74	-0.03	-0.08
Capex To Depreciation	-0.12	-0.39	0.68	0.91	0.01	-0.79	0.79		-0.39	-0.26	-0.8	0.16	0.07	-0.77	-0.31	-0.15	-0.57	0.99	0.95	0.32	-0.43	-0.97	0.32	0.9	0.03	0.31
Pb Ratio	0.78	1.0	-0.33	-0.17	0.25	-0.17	-0.24	-0.39		0.82	-0.16	-0.46	-0.39	-0.09	0.32	-0.72	0.18	-0.37	-0.16	-0.11	-0.36	0.42	-0.11	-0.41	0.01	-0.48
Ev To Sales	0.99	0.82	-0.14	0.03	0.25	-0.37	-0.28	-0.26	0.82		-0.35	0.0	-0.15	-0.19	0.12	-0.85	-0.16	-0.2	0.03	-0.15	-0.66	0.31	-0.15	-0.28	0.11	0.05
Free Cash Flow Per Share	-0.47	-0.16	-0.48	-0.86	-0.08	1.0	-0.67	-0.8	-0.16	-0.35		-0.02	0.07	0.92	0.19	0.66	0.62	-0.82	-0.92	-0.26	0.78	0.73	-0.26	-0.65	-0.05	-0.22
Roic	0.05	-0.46	0.44	0.23	0.31	-0.05	-0.3	0.16	-0.46	0.0	-0.02		0.53	0.13	-0.37	0.13	-0.47	0.2	0.17	-0.24	-0.2	-0.2	-0.24	0.24	0.13	0.88
Inventory Turnover	-0.14	-0.39	0.22	0.06	0.14	0.06	-0.14	0.07	-0.39	-0.15	0.07	0.53		0.09	-0.85	0.45	-0.59	0.16	0.04	0.06	0.07	0.02	0.06	0.07	-0.59	0.24
Net Income Per Share	-0.27	-0.09	-0.21	-0.68	-0.01	0.87	-0.67	-0.77	-0.09	-0.19	0.92	0.13	0.09		0.15	0.48	0.54	-0.79	-0.81	-0.27	0.49	0.71	-0.27	-0.48	0.05	-0.08
Days Of Inventory On Hand	0.07	0.32	-0.4	-0.3	-0.05	0.19	-0.07	-0.31	0.32	0.12	0.19	-0.37	-0.85	0.15		-0.26	0.65	-0.39	-0.3	0.0	0.13	0.18	0.0	-0.27	0.7	-0.21
Payables Turnover	-0.9	-0.72	-0.14	-0.41	-0.12	0.68	-0.14	-0.15	-0.72	-0.85	0.66	0.13	0.45	0.48	-0.26		0.14	-0.16	-0.42	-0.06	0.84	0.12	-0.06	-0.13	-0.35	-0.08
Average Inventory	-0.25	0.18	-0.44	-0.61	-0.31	0.62	-0.3	-0.57	0.18	-0.16	0.62	-0.47	-0.59	0.54	0.65	0.14		-0.68	-0.64	0.12	0.48	0.43	0.12	-0.47	0.39	-0.43
Capex To Revenue	-0.06	-0.37	0.67	0.92	0.04	-0.82	0.77	0.99	-0.37	-0.2	-0.82	0.2	0.16	-0.79	-0.39	-0.16	-0.68		0.96	0.27	-0.47	-0.93	0.27	0.88	-0.05	0.33
Cash Per Share	0.18	-0.16	0.72	0.98	0.05	-0.93	0.74	0.95	-0.16	0.03	-0.92	0.17	0.04	-0.81	-0.3	-0.42	-0.64	0.96		0.3	-0.69	-0.89	0.3	0.89	0.08	0.33
Pocfratio	-0.1	-0.11	0.1	0.29	-0.5	-0.26	0.41	0.32	-0.11	-0.15	-0.26	-0.24	0.06	-0.27	0.0	-0.06	0.12	0.27	0.3		-0.14	-0.32	1.0	0.32	0.3	-0.21
Interest Coverage	-0.77	-0.36	-0.56	-0.74	-0.07	0.83	-0.31	-0.43	-0.36	-0.66	0.78	-0.2	0.07	0.49	0.13	0.84	0.48	-0.47	-0.69	-0.14		0.36	-0.13	-0.52	-0.25	-0.34
Capex To Operating Cash Flow	0.17	0.42	-0.68	-0.85	-0.07	0.72	-0.74	-0.97	0.42	0.31	0.73	-0.2	0.02	0.71	0.18	0.12	0.43	-0.93	-0.89	-0.32	0.36		-0.33	-0.87	-0.14	-0.37
Pfcf Ratio	-0.1	-0.11	0.1	0.29	-0.5	-0.25	0.4	0.32	-0.11	-0.15	-0.26	-0.24	0.06	-0.27	0.0	-0.06	0.12	0.27	0.3	1.0	-0.13	-0.33		0.32	0.29	-0.21
Days Payables Outstanding	-0.12	-0.41	0.88	0.94	-0.02	-0.69	0.74	0.9	-0.41	-0.28	-0.65	0.24	0.07	-0.48	-0.27	-0.13	-0.47	0.88	0.89	0.32	-0.52	-0.87	0.32		0.15	0.35
Income Quality	0.14	0.01	0.03	0.12	-0.29	-0.08	-0.03	0.03	0.01	0.11	-0.05	0.13	-0.59	0.05	0.7	-0.35	0.39	-0.05	0.08	0.3	-0.25	-0.14	0.29	0.15		0.3
Roe	0.11	-0.48	0.48	0.37	0.17	-0.24	-0.08	0.31	-0.48	0.05	-0.22	0.88	0.24	-0.08	-0.21	-0.08	-0.43	0.33	0.33	-0.21	-0.34	-0.37	-0.21	0.35	0.3

Click cells to compare fundamentals

Aytu BioScience Account Relationship Matchups

Aytu BioScience fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	2.36	1.28	0.21	0.0498	0.19	303.96
Ptb Ratio	0.69	0.61	0.44	0.14	0.57	3.34
Days Sales Outstanding	74.41	156.7	81.98	98.34	106.42	106.07
Book Value Per Share	413.11	163.77	31.36	11.78	5.0	596.6K
Free Cash Flow Yield	(0.43)	(0.34)	(1.42)	(0.96)	(0.0879)	(0.31)
Operating Cash Flow Per Share	(123.36)	(30.91)	(19.61)	(1.54)	(0.25)	(611.3K)
Stock Based Compensation To Revenue	0.039	0.0545	0.0543	0.0563	0.036	8.48
Capex To Depreciation	0.0288	0.0219	0.25	0.0954	0.11	0.1
Pb Ratio	0.69	0.61	0.44	0.14	0.57	3.34
Ev To Sales	0.7	0.96	0.2	(0.0119)	0.13	337.23
Free Cash Flow Per Share	(123.36)	(33.7)	(19.61)	(1.54)	(0.25)	(612.4K)
Roic	(0.0592)	(0.23)	0.58	(0.31)	(0.14)	(1.03)
Net Income Per Share	(1.2K)	(59.22)	(69.39)	(5.1)	(2.86)	(619.9K)
Days Of Inventory On Hand	483.22	163.69	89.21	107.4	174.56	241.62
Payables Turnover	0.65	1.89	4.04	3.02	2.53	(7.05)
Research And Ddevelopement To Revenue	0.0623	0.0857	0.15	0.0381	0.0345	68.88
Capex To Revenue	0.0204	0.008176	0.0357	0.16	0.18	0.17
Cash Per Share	209.05	59.11	13.17	6.88	3.61	293.3K
Pocfratio	(2.3)	(3.24)	(0.7)	(1.04)	(11.37)	(3.26)
Capex To Operating Cash Flow	(0.004687)	(0.004327)	(0.0902)	(0.00169)	(0.001521)	(0.001597)
Pfcf Ratio	(2.3)	(2.97)	(0.7)	(1.04)	(11.37)	(3.25)
Days Payables Outstanding	562.5	192.91	90.35	120.67	144.25	(51.76)
Income Quality	2.08	0.45	0.26	0.3	0.0876	0.99
Roe	(0.14)	(0.42)	(2.36)	(0.43)	(0.57)	(1.04)
Ev To Operating Cash Flow	(0.68)	(2.42)	(0.66)	0.25	(7.86)	(3.61)
Pe Ratio	(4.8)	(1.44)	(0.19)	(0.31)	(1.0)	(3.21)
Return On Tangible Assets	(0.18)	(0.51)	(1.62)	(0.22)	(0.24)	(1.46)
Ev To Free Cash Flow	(0.68)	(2.22)	(0.66)	0.25	(7.86)	(3.61)
Earnings Yield	(0.21)	(0.69)	(5.36)	(3.19)	(1.0)	(0.31)
Net Debt To E B I T D A	3.77	0.73	0.0419	1.89	4.82	(37.19)
Current Ratio	2.65	0.96	0.93	1.06	0.99	0.54
Tangible Book Value Per Share	78.57	(16.31)	(16.69)	(5.87)	(4.47)	(314.5K)
Receivables Turnover	4.91	2.33	4.45	3.71	3.43	5.82
Graham Number	741.91	505.67	228.49	36.79	17.95	2.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Aytu Stock Analysis

When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Aytu Historical Financial Ratios

About Aytu Financial Ratios Analysis

Aytu BioScience Financial Ratios Chart

Price To Sales Ratio

Book Value Per Share

Ev To Free Cash Flow

Aytu BioScience fundamentals Correlations

Aytu BioScience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aytu BioScience fundamentals Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Aytu Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Ev To Sales	+ 0.99	Price To Sales Ratio
Capex To Revenue	+ 0.99	Capex To Depreciation
Cash Per Share	+ 0.98	Book Value Per Share

Capex To Operating Cash Flow	- 0.97	Capex To Depreciation
Capex To Operating Cash Flow	- 0.93	Capex To Revenue
Cash Per Share	- 0.93	Operating Cash Flow Per Share
Cash Per Share	- 0.92	Free Cash Flow Per Share
Payables Turnover	- 0.9	Price To Sales Ratio
Capex To Operating Cash Flow	- 0.89	Cash Per Share